Trial · NCT03280030
Results by group103
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 103
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Complete Remission (CR) | Midostaurin: Part 2 | End of Consolidation Morphologic CRp | 3.3 | 95% Confidence Interval 0.08 to 17.22 | Percentage of participants |
| Percentage of Participants With Complete Remission (CR) | Placebo: Part 2 | End of Consolidation Morphologic CRp | 9.4 | 95% Confidence Interval 1.98 to 25.02 | Percentage of participants |
| Percentage of Participants With Complete Remission (CR) | Midostaurin: Part 2 | After treatment discontinuation CR | 10.0 | 95% Confidence Interval 2.11 to 26.53 | Percentage of participants |
| Percentage of Participants With Complete Remission (CR) | Placebo: Part 2 | After treatment discontinuation CR | 3.1 | 95% Confidence Interval 0.08 to 16.22 | Percentage of participants |
| Percentage of Participants With Complete Remission (CR) | Midostaurin: Part 2 | After treatment discontinuation Morphologic CRp | 0.0 | 95% Confidence Interval 0.00 to 11.57 | Percentage of participants |
| Percentage of Participants With Complete Remission (CR) | Placebo: Part 2 | After treatment discontinuation Morphologic CRp | 6.3 | 95% Confidence Interval 0.77 to 20.81 | Percentage of participants |
| Percentage of Participants With Cumulative Incidence of Relapse (CIR) | Midostaurin: Part 2 | 21 | Participants | ||
| Percentage of Participants With Cumulative Incidence of Relapse (CIR) | Placebo: Part 2 | 25 | Participants | ||
| Pharmakinetics (PK) for Midostaurin: AUClast & AUC0-t | Midostaurin: Part 2 | AUClast | 17900 | Geometric Coefficient of Variation 53.5 | ng*hr/mL |
| Pharmakinetics (PK) for Midostaurin: AUClast & AUC0-t | Midostaurin: Part 2 | AUC0-t | 19200 | Geometric Coefficient of Variation 49.0 | ng*hr/mL |
| Pharmakinetics (PK) for Midostaurin: Cmax | Midostaurin: Part 2 | 2420 | Geometric Coefficient of Variation 46.5 | ng/mL | |
| Metabolite CGP52421: PK Parameters AUClast, AUC0-t | Midostaurin: Part 2 | AUClast | 754 | Geometric Coefficient of Variation 116 | ng*hr/mL |
| Metabolite CGP52421: PK Parameters AUClast, AUC0-t | Midostaurin: Part 2 | AUC0-t | 876 | Geometric Coefficient of Variation 92.3 | ng*hr/mL |
| Metabolite CGP52421: PK Parameter Cmax | Midostaurin: Part 2 | 98.6 | Geometric Coefficient of Variation 83.5 | ng/mL | |
| Metabolite CGP62221: PK Parameters: AUClast, AUC0-t | Midostaurin: Part 2 | AUClast | 1430 | Geometric Coefficient of Variation 223 | ng*hr/mL |
| Metabolite CGP62221: PK Parameters: AUClast, AUC0-t | Midostaurin: Part 2 | AUC0-t | 1730 | Geometric Coefficient of Variation 182 | ng*hr/mL |
| Metabolite CGP62221: PK Parameter: Cmax | Midostaurin: Part 2 | 196 | Geometric Coefficient of Variation 159 | ng/mL | |
| Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 | Midostaurin: Part 2 | EOI: Global health status (GHS):GHS | 27.8 | Standard Deviation 31.03 | scores on a scale |
| Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 | Placebo: Part 2 | EOI: Global health status (GHS):GHS | 0.0 | Standard Deviation 16.67 | scores on a scale |
| Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 | Midostaurin: Part 2 | EOCons: GHS:GHS | 20.8 | Standard Deviation 11.49 | scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03280030/results?page=2